265 related articles for article (PubMed ID: 24684724)
1. CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells.
Erb U; Megaptche AP; Gu X; Büchler MW; Zöller M
J Hematol Oncol; 2014 Mar; 7():29. PubMed ID: 24684724
[TBL] [Abstract][Full Text] [Related]
2. CD44v10, osteopontin and lymphoma growth retardation by a CD44v10-specific antibody.
Megaptche AP; Erb U; Büchler MW; Zöller M
Immunol Cell Biol; 2014 Sep; 92(8):709-20. PubMed ID: 24935458
[TBL] [Abstract][Full Text] [Related]
3. Involvement of CD44 variant isoform v10 in progenitor cell adhesion and maturation.
Rösel M; Khaldoyanidi S; Zawadzki V; Zöller M
Exp Hematol; 1999 Apr; 27(4):698-711. PubMed ID: 10210328
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic alteration of bone marrow HSC and microenvironmental association in experimentally induced leukemia.
Basak P; Chatterjee S; Das M; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
Curr Stem Cell Res Ther; 2010 Dec; 5(4):379-86. PubMed ID: 20528754
[TBL] [Abstract][Full Text] [Related]
5. Cooperativity of CD44 and CD49d in leukemia cell homing, migration, and survival offers a means for therapeutic attack.
Singh V; Erb U; Zöller M
J Immunol; 2013 Nov; 191(10):5304-16. PubMed ID: 24127558
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD44 exon v10 in B-cell activation.
Rösel M; Föger N; Zöller M
Tissue Antigens; 1998 Aug; 52(2):99-113. PubMed ID: 9756398
[TBL] [Abstract][Full Text] [Related]
7. Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization.
Rajasagi M; von Au A; Singh R; Hartmann N; Zöller M; Marhaba R
J Cell Mol Med; 2010 Jun; 14(6B):1453-67. PubMed ID: 19765170
[TBL] [Abstract][Full Text] [Related]
8. Anti-CD44-mediated blockade of leukocyte migration in skin-associated immune diseases.
Zöller M; Gupta P; Marhaba R; Vitacolonna M; Freyschmidt-Paul P
J Leukoc Biol; 2007 Jul; 82(1):57-71. PubMed ID: 17442857
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-associated changes in CD44 isoform expression during normal hematopoiesis and their alteration in chronic myeloid leukemia.
Ghaffari S; Dougherty GJ; Lansdorp PM; Eaves AC; Eaves CJ
Blood; 1995 Oct; 86(8):2976-85. PubMed ID: 7579390
[TBL] [Abstract][Full Text] [Related]
10. CD44v10 in hematopoiesis and stem cell mobilization.
Zoeller M
Leuk Lymphoma; 2000 Aug; 38(5-6):463-80. PubMed ID: 10953967
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells.
Bendall LJ; Bradstock KF; Gottlieb DJ
Leukemia; 2000 Jul; 14(7):1239-46. PubMed ID: 10914548
[TBL] [Abstract][Full Text] [Related]
12. CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.
Zöller M
Front Immunol; 2015; 6():235. PubMed ID: 26074915
[TBL] [Abstract][Full Text] [Related]
13. CD44 variant isoform v10 is expressed on tumor-infiltrating lymphocytes and mediates hyaluronan-independent heterotypic cell-cell adhesion to melanoma cells.
Weimann TK; Wagner C; Goos M; Wagner SN
Exp Dermatol; 2003 Apr; 12(2):204-12. PubMed ID: 12702150
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD44 splice variants in human skin and epidermal tumours.
Seiter S; Tilgen W; Herrmann K; Schadendorf D; Patzelt E; Möller P; Zöller M
Virchows Arch; 1996 Jun; 428(3):141-9. PubMed ID: 8688968
[TBL] [Abstract][Full Text] [Related]
15. CD44v10 expression in the mouse and functional activity in delayed type hypersensitivity.
Rösel M; Seiter S; Zöller M
J Cell Physiol; 1997 Jun; 171(3):305-17. PubMed ID: 9180900
[TBL] [Abstract][Full Text] [Related]
16. Expression of CD44 variant isoforms in peripheral blood leukocytes in malignant lymphoma and leukemia: inverse correlation between expression and tumor progression.
Khaldoyanidi S; Achtnich M; Hehlmann R; Zöller M
Leuk Res; 1996 Oct; 20(10):839-51. PubMed ID: 8960109
[TBL] [Abstract][Full Text] [Related]
17. CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells.
Ghazi-Visser L; Laman JD; Nagel S; van Meurs M; van Riel D; Tzankov A; Frank S; Adams H; Wolk K; Terracciano L; Melief MJ; Sabat R; Günthert U
FASEB J; 2013 Sep; 27(9):3683-701. PubMed ID: 23752202
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in the bone marrow stem cell niche generate specialized microenvironments for the distinct regulation of normal hematopoietic and leukemia stem cells.
Lee GY; Jeong SY; Lee HR; Oh IH
Sci Rep; 2019 Jan; 9(1):1007. PubMed ID: 30700727
[TBL] [Abstract][Full Text] [Related]
19. The hematopoietic stem-cell niche in health and leukemia.
Sánchez-Aguilera A; Méndez-Ferrer S
Cell Mol Life Sci; 2017 Feb; 74(4):579-590. PubMed ID: 27436341
[TBL] [Abstract][Full Text] [Related]
20. The leukemic stem cell niche: current concepts and therapeutic opportunities.
Lane SW; Scadden DT; Gilliland DG
Blood; 2009 Aug; 114(6):1150-7. PubMed ID: 19401558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
